{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T13:48:15Z","timestamp":1790171295272,"version":"4.1.0"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T00:00:00Z","timestamp":1733875200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["IK2HX003007"],"award-info":[{"award-number":["IK2HX003007"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug and Alcohol Dependence Reports"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.dadr.2024.100311","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T22:55:25Z","timestamp":1734130525000},"page":"100311","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Receipt of medications for opioid use disorder among rural and urban veterans health administration patients"],"prefix":"10.1016","volume":"14","author":[{"given":"Olivia C.","family":"Reynolds","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen F.","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L.","family":"Handley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin J.","family":"Morasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd P.","family":"Korthuis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Travis I.","family":"Lovejoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica J.","family":"Wyse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dadr.2024.100311_bib1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jsat.2018.07.006","article-title":"Increased distance was associated with lower daily attendance to an opioid treatment program in Spokane County Washington","volume":"93","author":"Amiri","year":"2018","journal-title":"J. Subst. Abus. Treat."},{"issue":"2","key":"10.1016\/j.dadr.2024.100311_bib3","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jval.2020.08.2098","article-title":"Disparities in access to opioid treatment programs and office-based buprenorphine treatment across the rural-urban and area deprivation continua: a US nationwide small area analysis","volume":"24","author":"Amiri","year":"2021","journal-title":"Value Health"},{"key":"10.1016\/j.dadr.2024.100311_bib4","article-title":"Prevalence of mental health disorders among individuals enrolled in an emergency response program for treatment of opioid use disorder","volume":"14","author":"Bakos-Block","year":"2020","journal-title":"Subst. Abu.: Res. Treat."},{"issue":"5","key":"10.1016\/j.dadr.2024.100311_bib5","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3390\/healthcare9050604","article-title":"Exploring health outcomes for U.S. veterans compared to non-veterans from 2003 to 2019","volume":"9","author":"Betancourt","year":"2021","journal-title":"Healthcare"},{"issue":"1","key":"10.1016\/j.dadr.2024.100311_bib6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/s41398-020-0847-1","article-title":"America\u2019s opioid crisis: the need for an integrated public health approach","volume":"10","author":"Blanco","year":"2020","journal-title":"Transl. Psychiatry"},{"issue":"S2","key":"10.1016\/j.dadr.2024.100311_bib7","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1007\/s11606-011-1762-1","article-title":"Distance is relative: unpacking a principal barrier in rural healthcare","volume":"26","author":"Buzza","year":"2011","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.dadr.2024.100311_bib8","doi-asserted-by":"crossref","first-page":"e2417545","DOI":"10.1001\/jamanetworkopen.2024.17545","article-title":"Availability of Medications for Opioid Use Disorder in Community Mental Health Facilities","volume":"7","author":"Cantor","year":"2024","journal-title":"JAMA Net. Open"},{"issue":"4","key":"10.1016\/j.dadr.2024.100311_bib9","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/YCO.0000000000000717","article-title":"The rise of illicit fentanyls, stimulants and the fourth wave of the opioid overdose crisis","volume":"34","author":"Ciccarone","year":"2021","journal-title":"Curr. Opin. Psychiatry"},{"key":"10.1016\/j.dadr.2024.100311_bib10","author":"Cowper","year":"2017","journal-title":"Rural Veterans Health Care Atlas, 2nd Ed. FY-2015"},{"issue":"1","key":"10.1016\/j.dadr.2024.100311_bib12","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1186\/s12913-019-4815-5","article-title":"Access to specialty healthcare in urban versus rural US populations: a systematic literature review","volume":"19","author":"Cyr","year":"2019","journal-title":"BMC Health Serv. Res."},{"issue":"25","key":"10.1016\/j.dadr.2024.100311_bib13","doi-asserted-by":"crossref","first-page":"567","DOI":"10.15585\/mmwr.mm7325a1","article-title":"Treatment for opioid use disorder: population estimates \u2014 United States, 2022","volume":"73","author":"Dowell","year":"2024","journal-title":"Mmwr. Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.dadr.2024.100311_bib14","unstructured":"Drug Overdose Death Rates. 2023. [Trends-Statistics]. National Institute on Drug Abuse. \u3008https:\/\/nida.nih.gov\/research-topics\/trends-statistics\/overdose-death-rates#:~:text=Opioid%2Dinvolved%20overdose%20deaths%20rose,with%2080%2C411%20reported%20overdose%20deaths\u3009. (accessed 8.29.23)."},{"key":"10.1016\/j.dadr.2024.100311_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2024.104487","article-title":"Comparing methadone policy and practice in France and the US: implications for US policy reform","volume":"129","author":"Englander","year":"2024","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.dadr.2024.100311_bib16","unstructured":"Ernstmeyer, K., Christman, E., Chippewa Valley Technical College, 2022Open Resources for Nursing (Open RN), Nursing Management and Professional Concepts."},{"key":"10.1016\/j.dadr.2024.100311_bib17","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.drugalcdep.2016.01.013","article-title":"Receipt of pharmacotherapy for opioid use disorder by justice-involved U.S. Veterans Health Administration patients","volume":"160","author":"Finlay","year":"2016","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.dadr.2024.100311_bib19","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/ADM.0000000000000719","article-title":"Disparities in access to medications for opioid use disorder in the veterans health administration","volume":"15","author":"Finlay","year":"2021","journal-title":"J. Addict. Med."},{"issue":"2","key":"10.1016\/j.dadr.2024.100311_bib20","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/ADM.0000000000000726","article-title":"Associations between polysubstance use patterns and receipt of medications for opioid use disorder among adults in treatment for opioid use disorder","volume":"15","author":"Ford","year":"2021","journal-title":"J. Addict. Med."},{"issue":"10","key":"10.1016\/j.dadr.2024.100311_bib21","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.36298","article-title":"Use of and retention on video, telephone, and in-person buprenorphine treatment for opioid use disorder during the COVID-19 pandemic","volume":"5","author":"Frost","year":"2022","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.dadr.2024.100311_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2019.06.029","article-title":"U.S. trends in the supply of providers with a waiver to prescribe buprenorphine for opioid use disorder in 2016 and 2018","volume":"204","author":"Ghertner","year":"2019","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.dadr.2024.100311_bib23","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/08897077.2020.1787299","article-title":"Stepped care for opioid use disorder train the trainer (SCOUTT) initiative: expanding access to medication treatment for opioid use disorder within veterans health administration facilities","volume":"41","author":"Gordon","year":"2020","journal-title":"Subst. Abus."},{"key":"10.1016\/j.dadr.2024.100311_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2023.109902","article-title":"Buprenorphine use and courses of care for opioid use disorder treatment within the Veterans Health Administration","volume":"248","author":"Gordon","year":"2023","journal-title":"Drug Alcohol Depend."},{"issue":"6","key":"10.1016\/j.dadr.2024.100311_bib25","doi-asserted-by":"crossref","first-page":"S230","DOI":"10.1016\/j.amepre.2017.12.022","article-title":"Policy pathways to address provider workforce barriers to buprenorphine treatment","volume":"54","author":"Haffajee","year":"2018","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.dadr.2024.100311_bib26","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.drugalcdep.2019.01.031","article-title":"Polydrug use disorders in individuals with opioid use disorder","volume":"198","author":"Hassan","year":"2019","journal-title":"Drug Alcohol Depend."},{"issue":"1","key":"10.1016\/j.dadr.2024.100311_bib27","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13722-021-00263-5","article-title":"Clinical leaders and providers\u2019 perspectives on delivering medications for the treatment of opioid use disorder in Veteran Affairs\u2019 facilities","volume":"16","author":"Hawkins","year":"2021","journal-title":"Addict. Sci. Clin. Pract."},{"issue":"5","key":"10.1016\/j.dadr.2024.100311_bib28","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1007\/s11606-020-06339-3","article-title":"Validity of incident opioid use disorder (OUD) diagnoses in administrative data: a chart verification study","volume":"36","author":"Howell","year":"2021","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.dadr.2024.100311_bib29","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2024.19914","article-title":"Methadone\u2019s moment","author":"Incze","year":"2024","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.dadr.2024.100311_bib30","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/jrh.12260","article-title":"Medication-assisted opioid treatment prescribers in federally qualified health centers: capacity lags in rural areas","volume":"34","author":"Jones","year":"2018","journal-title":"J. Rural Health"},{"issue":"8","key":"10.1016\/j.dadr.2024.100311_bib31","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.27488","article-title":"Use of medication for opioid use disorder among adults with past-year opioid use disorder in the US, 2021","volume":"6","author":"Jones","year":"2023","journal-title":"JAMA Netw. Open"},{"issue":"3","key":"10.1016\/j.dadr.2024.100311_bib32","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/08897077.2021.1975344","article-title":"Research priorities for expanding access to methadone treatment for opioid use disorder in the United States: a national institute on drug abuse clinical trials network task force report","volume":"42","author":"Joudrey","year":"2021","journal-title":"Subst. Abus."},{"issue":"13","key":"10.1016\/j.dadr.2024.100311_bib33","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1001\/jama.2019.12562","article-title":"Drive times to opioid treatment programs in urban and rural counties in 5 US States","volume":"322","author":"Joudrey","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.dadr.2024.100311_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108583","article-title":"Identifying individuals with opioid use disorder: validity of international classification of diseases diagnostic codes for opioid use, dependence and abuse","volume":"221","author":"Lagisetty","year":"2021","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.dadr.2024.100311_bib35","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.1864","article-title":"Rates of primary care and integrated mental health telemedicine visits between rural and urban veterans affairs beneficiaries before and after the onset of the COVID-19 pandemic","volume":"6","author":"Leung","year":"2023","journal-title":"JAMA Netw. Open"},{"issue":"3","key":"10.1016\/j.dadr.2024.100311_bib36","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1080\/00952990.2019.1694536","article-title":"A systematic review of rural-specific barriers to medication treatment for opioid use disorder in the United States","volume":"46","author":"Lister","year":"2020","journal-title":"Am. J. Drug Alcohol Abus."},{"key":"10.1016\/j.dadr.2024.100311_bib37","unstructured":"Medications for the Treatment of Opioid Use Disorder, Department of Health and Human Services, 42C.F.R. 8 Department of Health and Human Services, 202442C.F.R. 8 \u3008https:\/\/www.federalregister.gov\/documents\/2024\/02\/02\/2024-01693\/medications-for-the-treatment-of-opioid-use-disorder\u3009."},{"issue":"1","key":"10.1016\/j.dadr.2024.100311_bib38","article-title":"US veterans who do and do not utilize veterans affairs health care services: demographic, military, medical, and psychosocial characteristics","volume":"21","author":"Meffert","year":"2019","journal-title":"Prim. Care Companion CNS Disord."},{"key":"10.1016\/j.dadr.2024.100311_bib39","series-title":"Medications for Opioid Use Disorder Save Lives","author":"National Academies of Sciences","year":"2019"},{"key":"10.1016\/j.dadr.2024.100311_bib40","unstructured":"National Drug Control Strategy 2022."},{"issue":"2","key":"10.1016\/j.dadr.2024.100311_bib42","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1176\/appi.ps.20230087","article-title":"Availability of medication for opioid use disorder among accountable care organizations: evidence from a national survey","volume":"75","author":"Newton","year":"2024","journal-title":"Psychiatr. Serv."},{"issue":"3","key":"10.1016\/j.dadr.2024.100311_bib43","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1111\/jrh.12805","article-title":"Understanding rural-urban differences in veterans\u2019 internet access, use and patient preferences for telemedicine","volume":"40","author":"O\u2019Shea","year":"2024","journal-title":"J. Rural Health"},{"issue":"3","key":"10.1016\/j.dadr.2024.100311_bib44","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.drugalcdep.2011.10.004","article-title":"Receipt of opioid agonist treatment in the Veterans Health Administration: facility and patient factors","volume":"122","author":"Oliva","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.dadr.2024.100311_bib45","unstructured":"Opioid Use Disorder Fact Sheet: Data on Patients Using VA Health Care. Cooperative Studies Program. 2022. [Fact sheet]. Office of Research and Development, Department of Veterans Affairs.."},{"issue":"2","key":"10.1016\/j.dadr.2024.100311_bib46","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1080\/08897077.2018.1449174","article-title":"Implementation and evaluation of an opioid overdose education and naloxone distribution (OEND) program at a veterans affairs medical center","volume":"39","author":"Pauly","year":"2018","journal-title":"Subst. Abus."},{"issue":"1","key":"10.1016\/j.dadr.2024.100311_bib49","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.japh.2022.10.019","article-title":"Implementing syringe services programs within the Veterans Health Administration: facility experiences and next steps","volume":"63","author":"Rife-Pennington","year":"2023","journal-title":"J. Am. Pharm. Assoc.: JAPhA"},{"issue":"4","key":"10.1016\/j.dadr.2024.100311_bib50","first-page":"300","article-title":"Rural veterans less likely to get medication for opioid use disorder","volume":"323","author":"Rubin","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.dadr.2024.100311_bib51","unstructured":"SAMHSA Applauds Expansion of Access to Medication for Opioid Use Disorder (MOUD). (2023, January 18). SAMHSA. \u3008https:\/\/www.samhsa.gov\/newsroom\/statements\/2023\/samhsa-applauds-expansion-access-moud\u3009"},{"issue":"1","key":"10.1016\/j.dadr.2024.100311_bib52","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13722-023-00405-x","article-title":"Validating opioid use disorder diagnoses in administrative data: a commentary on existing evidence and future directions","volume":"18","author":"Scherrer","year":"2023","journal-title":"Addict. Sci. Clin. Pract."},{"issue":"3","key":"10.1016\/j.dadr.2024.100311_bib55","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1037\/rmh0000187","article-title":"Medication for opioid use disorder in rural America: a review of the literature","volume":"45","author":"Showers","year":"2021","journal-title":"J. Rural Ment. Health"},{"issue":"3","key":"10.1016\/j.dadr.2024.100311_bib56","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s11606-022-07891-w","article-title":"Buprenorphine treatment episodes during the first year of COVID: a retrospective examination of treatment initiation and retention","volume":"38","author":"Stein","year":"2023","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.dadr.2024.100311_bib57","doi-asserted-by":"crossref","first-page":"69","DOI":"10.2147\/SAR.S116720","article-title":"Substance use disorders in military veterans: prevalence and treatment challenges","volume":"8","author":"Teeters","year":"2017","journal-title":"Subst. Abus. Rehabil."},{"issue":"4","key":"10.1016\/j.dadr.2024.100311_bib58","doi-asserted-by":"crossref","first-page":"e265","DOI":"10.1097\/ADM.0000000000000922","article-title":"Evidence of buprenorphine-precipitated withdrawal in persons who use fentanyl","volume":"16","author":"Varshneya","year":"2022","journal-title":"J. Addict. Med."},{"issue":"12","key":"10.1016\/j.dadr.2024.100311_bib59","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1007\/s11606-024-08898-1","article-title":"Integrating medications for opioid use disorder into rural primary care settings","volume":"39","author":"Wyse","year":"2024","journal-title":"J. Gen. Intern. Med."},{"issue":"2","key":"10.1016\/j.dadr.2024.100311_bib60","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/08897077.2018.1452327","article-title":"Medications for opioid use disorder in the Department of Veterans Affairs (VA) health care system: historical perspective, lessons learned, and next steps","volume":"39","author":"Wyse","year":"2018","journal-title":"Subst. Abus."},{"key":"10.1016\/j.dadr.2024.100311_bib61","doi-asserted-by":"crossref","DOI":"10.1111\/1475-6773.14346","article-title":"Improving access to buprenorphine for rural veterans in a learning health care system","author":"Wyse","year":"2024","journal-title":"Health Serv. Res."},{"key":"10.1016\/j.dadr.2024.100311_bib62","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s10461-021-03452-0","article-title":"Twelve-month retention in opioid agonist treatment for opioid use disorder among patients with and without HIV","volume":"26","author":"Wyse","year":"2022","journal-title":"AIDS Behav."},{"key":"10.1016\/j.dadr.2024.100311_bib63","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.drugalcdep.2019.01.038","article-title":"Predictors of timely opioid agonist treatment initiation among veterans with and without HIV","volume":"198","author":"Wyse","year":"2019","journal-title":"Drug Alcohol Depend."},{"issue":"8","key":"10.1016\/j.dadr.2024.100311_bib64","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1007\/s11606-023-08027-4","article-title":"Access to medications for opioid use disorder in rural versus urban veterans health administration facilities","volume":"38","author":"Wyse","year":"2023","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.dadr.2024.100311_bib65","article-title":"Co-occurring psychiatric disorders and disparities in buprenorphine utilization in opioid use disorder: an analysis of insurance claims","volume":"9","author":"Xu","year":"2023","journal-title":"Drug Alcohol Depend. Rep."},{"issue":"5","key":"10.1016\/j.dadr.2024.100311_bib66","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.11363","article-title":"Comparative effectiveness associated with buprenorphine and naltrexone in opioid use disorder and cooccurring polysubstance use","volume":"5","author":"Xu","year":"2022","journal-title":"JAMA Netw. Open"}],"updated-by":[{"DOI":"10.1016\/j.dadr.2025.100319","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000}}],"container-title":["Drug and Alcohol Dependence Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724624000957?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772724624000957?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T00:12:35Z","timestamp":1762647155000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772724624000957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":58,"alternative-id":["S2772724624000957"],"URL":"https:\/\/doi.org\/10.1016\/j.dadr.2024.100311","relation":{},"ISSN":["2772-7246"],"issn-type":[{"value":"2772-7246","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Receipt of medications for opioid use disorder among rural and urban veterans health administration patients","name":"articletitle","label":"Article Title"},{"value":"Drug and Alcohol Dependence Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dadr.2024.100311","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100311"}}